![](/img/cover-not-exists.png)
An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis
Cory M. Hogaboam, Milan J. Muller, Stephen M. Collins, Richard H. HuntVolume:
309
Year:
1996
Language:
english
Pages:
270
DOI:
10.1016/0014-2999(96)00276-2
File:
PDF, 1.15 MB
english, 1996